Home Media Media center Diaccurate Adds Merck PAM Inhibitor to Oncology/Immunology Pipeline September 9, 2021 Merck KGaA entrusts secretive startup with a mid-stage cancer drug targeting master signaling pathway September 8, 2021 Could HIV be cured by tackling ‘bumpy’ CD4 cells? France’s Diaccurate wants to find out August 12, 2021 Philippe Pouletty explains the discovery of Diaccurate on the BFM Business show (in French) March 4, 2020 Diaccurate opens a new therapeutic avenue for AIDS (in French) March 4, 2020 Major discovery by French biotech Diaccurate in the treatment of AIDS, with the promise of remission (in French) March 3, 2020
Merck KGaA entrusts secretive startup with a mid-stage cancer drug targeting master signaling pathway September 8, 2021
Could HIV be cured by tackling ‘bumpy’ CD4 cells? France’s Diaccurate wants to find out August 12, 2021
Philippe Pouletty explains the discovery of Diaccurate on the BFM Business show (in French) March 4, 2020
Major discovery by French biotech Diaccurate in the treatment of AIDS, with the promise of remission (in French) March 3, 2020
